Manufacturer record
Concept Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Concept Pharmaceuticals Ltd (Maharashtra) were declared Not of Standard Quality between December 2020 and January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
11 records linked to Concept Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metformin Hydrochloride Sustained Release Tablets I.P. 500mg (Conmet SR- 500) | C21D93400 3Mfg 2024-06 · Exp 2027-05 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2025 |
| Aluminium, Magnesium &Simethicone Oral Suspension I.P | C21A133003Mfg 2023-06 · Exp 2026-05 | Description onlyDescription | State Lab KarnatakaState lab | Dec 2024 |
| Ofloxacin Dispersible Tablets IP 100 mg (Oflab 100 DT) | C21O062001Mfg 2022-05 · Exp 2024-04 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Feb 2024 |
| Isoniazid Tablets IP 300 mg (Isocon -300) | C21I263005Mfg 2023-07 · Exp 2027-06 | AssayAssay | CDTL MumbaiCDSCO lab | Oct 2023 |
| Albendazole Tablets I.P. 400 mg | C21F943011Mfg 2023-08 · Exp 2026-07 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Oct 2023 |
| Rifampicin, Isoniazid, Pyrazinamide & Ethambutol Tablets I.P. (HRZE) | C21R772013Mfg 2022-01 · Exp 2023-12 | Assay of RifampicinAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Ibuprofen and Paracetamol Dispersible Tablets (Ibucon Plus Kid) | C211143 003Mfg 2023-03 · Exp 2026-02 | Diameter & Uniformity of DispersionUniformity of weight/content | CDTL MumbaiCDSCO lab | Aug 2023 |
| Losacon-H (Losartan Potassium & Hydrochlorothiazide Tablets I.P.) | C21L262001Mfg 2022-02 · Exp 2024-01 | Assay of HydrochlorthiazideAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Telmicept 40 (Telmisartan Tablets I.P. 40 mg) | C21T479003Mfg 2019-09 · Exp 2022-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2021 |
| TELMISARTAN TABLETS I.P. 40 mg (TELMICEPT-40 TABLETS) | C21T470002Mfg 2020-07 · Exp 2023-06 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2021 |
| Telmicept ? 40 (Telmisartan Tablets I.P. 40 mg) | C21T479003Mfg 2019-09 · Exp 2022-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.